The score is driven primarily by solid operating performance and a strong, low-leverage balance sheet, partially offset by weak cash flow (negative free cash flow). Technicals show a strong uptrend but overbought readings increase short-term risk, while valuation is supportive due to a reasonable P/E despite a low dividend yield.
Positive Factors
Profitability & margins
Consistently strong and improving margins indicate durable pricing power and effective cost control in the company's chemical operations. Sustained gross and operating margins support internal reinvestment, buffer raw-material volatility and provide operating leverage that should persist over the next several quarters.
Low leverage / strong balance sheet
A conservative capital structure with very low leverage and a high equity ratio materially reduces financial risk. This structural strength provides flexibility to fund capex or selective M&A, maintain investment-grade stability through cycles, and limits interest expense pressure over the medium term.
Stable operating performance and prudent capital management
The firm's operating consistency combined with conservative capital deployment creates durable resilience against industry cyclicality. Persistent operational efficiency and disciplined balance-sheet management support steady execution, enabling the company to pursue strategic initiatives while retaining financial stability.
Negative Factors
Weak cash generation / negative FCF
Significant negative free cash flow and declining operating cash conversion limit internal funding capacity for capex, R&D and dividends. Over the coming months this structural cash weakness could force reliance on external financing or delay strategic investments, constraining growth execution despite healthy accounting profits.
Modest return on equity
An ROE under 7% suggests the company generates only modest returns on shareholder capital. Persistently moderate ROE can limit long-term value creation and reduce the firm's ability to self-fund strategic expansion, pressuring management to improve asset efficiency or redeploy capital more effectively.
Limited scale
A small workforce implies limited scale relative to larger chemical competitors, which can constrain R&D depth, production footprint and commercial reach. Over time limited scale may hinder cost competitiveness, slow market expansion and reduce bargaining power with suppliers and customers.
Hosoya Pyroengineering Co., Ltd. (4274) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥5.60B
Dividend Yield0.98%
Average Volume (3M)17.84K
Price to Earnings (P/E)11.0
Beta (1Y)0.72
Revenue Growth-4.35%
EPS Growth-19.25%
CountryJP
Employees90
SectorBasic Materials
Sector Strength58
IndustryChemicals
Share Statistics
EPS (TTM)23.18
Shares Outstanding4,032,000
10 Day Avg. Volume30,150
30 Day Avg. Volume17,843
Financial Highlights & Ratios
PEG Ratio0.33
Price to Book (P/B)1.33
Price to Sales (P/S)2.08
P/FCF Ratio-31.75
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Hosoya Pyroengineering Co., Ltd. Business Overview & Revenue Model
Company DescriptionHosoya Pyro-Engineering Co., Ltd. researches, develops, manufactures, tests, evaluates, and sells pyrotechnic products for leisure and space industries in Japan. The company offers smoke canisters, signal bullets, inflators, and wire cutters products. It is also involved in the combustion disposal of explosives; and research and development of liquid energy substances for space and defense. The company was formerly known as Hosoya Bussan Co., Ltd. and changed its name to Hosoya Pyro-Engineering Co., Ltd. in January 1954. Hosoya Pyro-Engineering Co., Ltd. was founded in 1906 and is headquartered in Akiruno, Japan.
Strong income statement trends (revenue up 11.3%, improved net margin to 10.8%, solid EBIT/EBITDA margins) and a healthy balance sheet (low leverage with 0.20 debt-to-equity, 71.3% equity ratio). Offsetting these positives, cash generation is a key weakness with negative free cash flow (-133.7M) and poor profit-to-cash conversion.
Income Statement
82
Very Positive
The company's income statement shows strong growth with a notable revenue increase of 11.3% from the previous year. Gross profit margin is solid at 32.3%, and the net profit margin improved to 10.8%, indicating enhanced profitability. The EBIT margin is 14.3%, and EBITDA margin stands at 18.0%, both reflecting operational efficiency. Overall, the income statement demonstrates positive trends in revenue and profitability, suggesting a well-managed cost structure.
Balance Sheet
78
Positive
The balance sheet reveals a stable financial position with a debt-to-equity ratio of 0.20, indicating low leverage and prudent risk management. The company has a strong equity ratio of 71.3%, which signifies a robust capital structure. Return on equity is 6.9%, showing an adequate return to shareholders. Overall, the company maintains a healthy balance sheet with low financial risk and solid equity backing, although ROE could be improved.
Cash Flow
65
Positive
The cash flow statement shows a decrease in operating cash flow, resulting in a negative free cash flow of -133.7 million. The free cash flow to net income ratio is negative, indicating challenges in converting profits to cash. While past years showed positive free cash flow growth, recent figures suggest potential cash management issues. Improvements in cash generation and capital allocation are needed to strengthen liquidity.
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4274, the sentiment is Neutral. The current price of 1016 is below the 20-day moving average (MA) of 1524.55, below the 50-day MA of 1292.96, and below the 200-day MA of 1088.39, indicating a neutral trend. The MACD of 45.97 indicates Positive momentum. The RSI at 47.14 is Neutral, neither overbought nor oversold. The STOCH value of 12.82 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:4274.
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 05, 2026